any reported association is likely indirect, relating to changes in body composition, posture, or activity levels during weight loss rather than a direct pharmacological effect
Advanced Bionutritionals GLP-1 Plus falls partially into this category with its 95% claim derived from preclinical models
Thijs Geijer & Diederik Stadig, Transformative or Overhyped
A pharmacy prescriber will check eligibility prior to approval
The obesity approval (Zepbound) followed in November 2023
Los criterios de elegibilidad para la seleccin de los artculos fueron: ensayos clnicos aleatorizados, en ingls y espaol, sobre la liraglutida comparado con otras estrategias teraputicas (placebo, dieta, sulfonilureas, tiazolidindionas, insulina u otros), los pacientes con diabetes mellitus tipo 2, con una intervencin mnima de 8 semanas y reporte sobre el peso